TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bionomen AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
9,519
|
17,272
|
8,412 |
| Financial expenses |
6
|
6
|
6 |
| Earnings before taxes |
699
|
3,095
|
1,068 |
| EBITDA |
687
|
3,101
|
1,079 |
| Total assets |
4,397
|
5,109
|
3,060 |
| Current assets |
4,376
|
5,078
|
3,021 |
| Current liabilities |
743
|
1,042
|
1,689 |
| Equity capital |
3,383
|
3,799
|
1,267 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.9%
|
74.4%
|
41.4% |
| Turnover per employee |
4,760
|
8,636
|
4,206 |
| Profit as a percentage of turnover |
7.3%
|
17.9%
|
12.7% |
| Return on assets (ROA) |
16.0%
|
60.7%
|
35.1% |
| Current ratio |
589.0%
|
487.3%
|
178.9% |
| Return on equity (ROE) |
20.7%
|
81.5%
|
84.3% |
| Change turnover |
-8,065
|
8,263
|
910 |
| Change turnover % |
-46%
|
92%
|
12% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.